SUVRETTA CAPITAL MANAGEMENT, LLC
Position in CRL — Charles River Laboratories International, Inc.
CIK 1569064
New York, NY
Position in CRL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$229,057
+$27,583 QoQ
Shares Held
1,010
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#391
of 569 holders
Holding Since
Dec 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026SUVRETTA CAPITAL MANAGEMENT, LLC holds $18,014,372 across 7 Diagnostics & Research names. CRL ranks #7 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
13,400 | $6,718,224 | |
| 2 | DHR |
Danaher Corp /De/
|
26,600 | $5,066,768 | |
| 3 | NTRA |
Natera, Inc.
|
10,100 | $2,741,645 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
7,175 | $1,386,353 | |
| 5 | WAT |
Waters Corp /De/
|
3,225 | $1,209,504 | |
| 6 | A |
Agilent Technologies, Inc.
|
4,990 | $662,821 | |
| 7 | CRL |
Charles River Laboratories International, Inc.
This page
|
1,010 | $229,057 |
All Filings in CRL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $229,057 | 1,010 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $201,474 | 1,010 | Shares | Sole | 2026-02-17 | |
| 2024-06-30 | $208,645 | 1,010 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $273,659 | 1,010 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $238,764 | 1,010 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $212,352 | 1,010 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $203,838 | 1,010 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $220,079 | 1,010 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||